Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.
AIDS Rev., 9(2):68-74 (2007)
IL-21 augments natural killer effector functions in chronically HIV-infected individuals.
AIDS., Aug;22(13):1551-60 (2008)
CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
AIDS., Oct;22(15):1937-41 (2008)
An academic center's delivery of care after the Haitian earthquake.
Ann. Intern. Med., Aug;153(4):262-5 (2010)
HIV-1 diversity after a class switch failure.
AIDS Res. Hum. Retroviruses., Nov;26(11):1175-80 (2010)
Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa.
Vaccine., Mar;29(14):2619-25 (2011)
In vitro enhancement of T-cell receptor-targeted lysis after IL-2 treatment of PBL from HIV-seropositive individuals.
Clin. Immunol. Immunopathol., Feb;86(2):226-34 (1998)
Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads.
AIDS., Mar;16(4):537-42 (2002)
An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice.
J. Pediatr., Nov;141(5):665-70 (2002)
Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals.
Clin. Diagn. Lab. Immunol., Sep;10(5):757-63 (2003)
Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance.
AIDS Res. Hum. Retroviruses., Aug;19(8):653-6 (2003)
The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study.
Int J STD AIDS., Nov;14(11):732-6 (2003)
Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naÃ¯ve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
HIV Med., Sep;5(5):364-70 (2004)
Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable?
IUBMB Life., Jun;56(6):301-7 (2004)
Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
Clin. Diagn. Lab. Immunol., Nov;11(6):1002-7 (2004)
Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir.
Clin. Diagn. Lab. Immunol., Jan;12(1):76-80 (2005)
Differences in presentation and outcome of invasive pneumococcal disease among patients with and without HIV infection in the pre-HAART era.
AIDS Patient Care STDS., Mar;19(3):141-9 (2005)
Race and ethnicity impact on the maximum proliferative response in peripheral blood lymphocytes from HIV-seropositive individuals.
HIV Med., Sep;8(6):401-5 (2007)
Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV).
Blood., May;109(9):3873-80 (2007)
Differences in HIV-related hospitalization trends between Haitian-born blacks and US-born blacks.
J. Acquir. Immune Defic. Syndr., Aug;45(5):529-34 (2007)